JP6120448B2 - Method for determining the conception rate of cattle - Google Patents
Method for determining the conception rate of cattle Download PDFInfo
- Publication number
- JP6120448B2 JP6120448B2 JP2014183157A JP2014183157A JP6120448B2 JP 6120448 B2 JP6120448 B2 JP 6120448B2 JP 2014183157 A JP2014183157 A JP 2014183157A JP 2014183157 A JP2014183157 A JP 2014183157A JP 6120448 B2 JP6120448 B2 JP 6120448B2
- Authority
- JP
- Japan
- Prior art keywords
- seq
- region
- mutation
- base
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000283690 Bos taurus Species 0.000 title claims description 55
- 238000000034 method Methods 0.000 title claims description 22
- 230000035772 mutation Effects 0.000 claims description 49
- 101150065336 Unc5c gene Proteins 0.000 claims description 47
- 239000003153 chemical reaction reagent Substances 0.000 claims description 17
- 108700028369 Alleles Proteins 0.000 claims description 12
- 230000014509 gene expression Effects 0.000 claims description 12
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical group O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims description 12
- 108020004707 nucleic acids Proteins 0.000 claims description 12
- 102000039446 nucleic acids Human genes 0.000 claims description 12
- 150000007523 nucleic acids Chemical class 0.000 claims description 12
- 229930024421 Adenine Natural products 0.000 claims description 6
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 6
- 229960000643 adenine Drugs 0.000 claims description 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 4
- KQLXBKWUVBMXEM-UHFFFAOYSA-N 2-amino-3,7-dihydropurin-6-one;7h-purin-6-amine Chemical group NC1=NC=NC2=C1NC=N2.O=C1NC(N)=NC2=C1NC=N2 KQLXBKWUVBMXEM-UHFFFAOYSA-N 0.000 claims 1
- 239000013615 primer Substances 0.000 description 50
- 108090000623 proteins and genes Proteins 0.000 description 22
- 230000035558 fertility Effects 0.000 description 14
- 239000012634 fragment Substances 0.000 description 14
- 239000000523 sample Substances 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 108060001084 Luciferase Proteins 0.000 description 8
- 238000009395 breeding Methods 0.000 description 8
- 230000001488 breeding effect Effects 0.000 description 8
- 230000037429 base substitution Effects 0.000 description 7
- 230000009027 insemination Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000000295 complement effect Effects 0.000 description 6
- 238000009396 hybridization Methods 0.000 description 6
- 108020005345 3' Untranslated Regions Proteins 0.000 description 5
- 206010064571 Gene mutation Diseases 0.000 description 5
- 244000309464 bull Species 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 230000003321 amplification Effects 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 101150012624 CTTNBP2NL gene Proteins 0.000 description 3
- 102100031725 Cortactin-binding protein 2 Human genes 0.000 description 3
- 101710113312 Cortactin-binding protein 2 Proteins 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 230000004720 fertilization Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000032696 parturition Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 102000010970 Connexin Human genes 0.000 description 1
- 108050001175 Connexin Proteins 0.000 description 1
- 108020001019 DNA Primers Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 238000003718 Dual-Luciferase Reporter Assay System Methods 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 102000005951 Netrin Receptors Human genes 0.000 description 1
- 108010030865 Netrin Receptors Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 101150032479 UNC-5 gene Proteins 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 210000003976 gap junction Anatomy 0.000 description 1
- 210000002503 granulosa cell Anatomy 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 238000003670 luciferase enzyme activity assay Methods 0.000 description 1
- 238000003468 luciferase reporter gene assay Methods 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000030363 nerve development Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
本発明は、ウシの受胎率の判定方法、判定試薬及び判定キットに関する。 The present invention relates to a method for determining the conception rate of a cow, a determination reagent, and a determination kit.
酪農家にとって、乳牛の泌乳能力の向上と共に繁殖性の改善は重要である。近年、ホルスタインの泌乳能力は飼養管理の改善及び遺伝改良により飛躍的に向上した一方、受胎率の低下が顕著である。受胎率の低下は、泌乳量の増大によるストレス等環境要因の影響だけでなく、繁殖性の改善のための遺伝改良を行っていなかったためと考えられる。 It is important for dairymen to improve fertility as well as improving the milking ability of dairy cows. In recent years, Holstein's lactation ability has improved dramatically due to improved feeding management and genetic improvements, while the conception rate has declined significantly. The decrease in conception rate is thought to be due to the fact that genetic improvements were not made to improve fertility, as well as the influence of environmental factors such as stress due to increased milk yield.
本願発明者らはこれまでに、ウシのCortactin binding protein 2 N-terminal-like (CTTNBP2NL)遺伝子が受胎率に関与すること、該遺伝子の3'UTRにおける塩基置換を指標として受胎率を評価できることを報告している(非特許文献1、2)。しかしながら、CTTNBP2NL遺伝子以外で受胎率評価の指標となる遺伝子は知られていない。 The inventors of the present application have previously confirmed that the bovine Cortactin binding protein 2 N-terminal-like (CTTNBP2NL) gene is involved in the conception rate, and that the conception rate can be evaluated using the base substitution in the 3′UTR of the gene as an index. (Non-Patent Documents 1 and 2). However, genes other than the CTTNBP2NL gene that serve as an index for evaluating the conception rate are not known.
受胎率に差をもたらす遺伝子の変異を検出する遺伝子診断法を確立すれば、受胎率の良い個体を迅速に検出できる。したがって、本発明は、受胎率の良いウシの迅速な検出に貢献できる、CTTNBP2NL遺伝子以外の新たな指標を提供することを目的とする。 Establishing a genetic diagnostic method that detects gene mutations that cause a difference in conception rate enables rapid detection of individuals with good conception rate. Therefore, an object of the present invention is to provide a new index other than the CTTNBP2NL gene, which can contribute to the rapid detection of cattle with good conception rate.
本願発明者らは、鋭意研究の結果、受胎率と密接に関連する遺伝子として新たにUNC5C遺伝子を同定することに成功し、本願発明を完成した。 As a result of intensive studies, the inventors of the present application succeeded in newly identifying the UNC5C gene as a gene closely related to the conception rate, and completed the present invention.
すなわち、本発明は、ウシから分離された核酸試料について、UNC5C遺伝子領域における変異の有無を検出することを含む、ウシの受胎率を判定する方法であって、前記変異は、UNC5C遺伝子の発現が抑制される変異であり、変異型アリルの存在が低受胎率の指標となる、方法を提供する。また、本発明は、UNC5C遺伝子領域内の変異部位を含む領域を増幅するためのプライマーセットを含む、ウシの受胎率の判定試薬であって、前記変異部位は、配列番号16における432番目の塩基である、判定試薬を提供する。さらに、本発明は、上記本発明の判定試薬を含む、ウシの受胎率の判定キットを提供する。
That is, the present invention is a method for determining the fertility rate of a bovine, comprising detecting the presence or absence of a mutation in the UNC5C gene region of a nucleic acid sample isolated from a bovine, wherein the mutation is expressed by the expression of the UNC5C gene. Provided is a method that is a suppressed mutation, wherein the presence of a mutant allele is an indicator of low conception rate. The present invention is also a bovine conception rate determination reagent comprising a primer set for amplifying a region containing a mutation site in the UNC5C gene region, wherein the mutation site is the 432th base in SEQ ID NO: 16. A determination reagent is provided. Furthermore, this invention provides the determination kit of the conception rate of a cow containing the determination reagent of the said invention.
本発明により、受胎率の高いウシを迅速に検出できる新たな方法が提供される。受胎率は複数の遺伝子が関わっている量的形質であるが、UNC5C遺伝子を単独で指標として用いた場合でも受胎率評価が可能である。UNC5C遺伝子変異と、受胎率判定の指標となる他の遺伝子変異を複数組み合わせて調べた場合には、受胎率の良いウシのスクリーニングの精度がさらに高まる。本発明は、繁殖性の改善のための遺伝改良のさらなる迅速化に貢献する。 The present invention provides a new method capable of rapidly detecting a cow with a high conception rate. The conception rate is a quantitative trait involving multiple genes, but it is possible to evaluate the conception rate even when the UNC5C gene is used alone as an indicator. When a combination of UNC5C gene mutations and other gene mutations that are used as an indicator for conception rate determination, the accuracy of screening for cows with good conception rates is further increased. The present invention contributes to further speeding up genetic improvement for improving fertility.
本発明において、「遺伝子領域」とは、タンパク質をコードする領域と、イントロン領域と、プロモーター領域、5'-及び3'-UTR等の当該遺伝子の発現の制御に関与し得る領域とを含む、ゲノム上の連続した領域をいう。具体的には、「UNC5C遺伝子領域」とは、配列表の配列番号1〜16に示した配列を含むゲノム上の領域である。配列番号1〜16は、UNC5C遺伝子の各エクソン及びその近傍のイントロンの配列を表1の通りに示したものである。 In the present invention, the `` gene region '' includes a region encoding a protein, an intron region, a promoter region, a region that can participate in the control of expression of the gene such as 5′- and 3′-UTR, A continuous region on the genome. Specifically, the “UNC5C gene region” is a region on the genome including the sequences shown in SEQ ID NOs: 1 to 16 in the sequence listing. SEQ ID NOs: 1 to 16 show the sequences of each exon of the UNC5C gene and introns in the vicinity thereof as shown in Table 1.
本発明において、遺伝子の変異とは、基準となる塩基配列と比較して相違する部分をいう。UNC5C遺伝子領域について基準となる塩基配列は、配列表の配列番号1〜16に示す塩基配列である。なお、配列番号20及び21には、UNC5C遺伝子のcDNAの塩基配列及び該遺伝子にコードされるタンパク質のアミノ酸配列をそれぞれ示した。 In the present invention, gene mutation refers to a portion that differs from a base sequence serving as a reference. The base sequence used as a reference for the UNC5C gene region is the base sequence shown in SEQ ID NOs: 1 to 16 in the sequence listing. In SEQ ID NOs: 20 and 21, the cDNA base sequence of UNC5C gene and the amino acid sequence of the protein encoded by the gene are shown, respectively.
UNC5C(unc-5 homolog C)遺伝子は、神経発達に関与するnetrin受容体タンパク質をコードする遺伝子である。本発明におけるUNC5C遺伝子領域の変異とは、ウシ体内でのUNC5C遺伝子の機能が低下する変異である。ウシ体内でのUNC5C遺伝子の機能の低下には、UNC5C遺伝子の発現量の低下等によりウシ体内での野生型UNC5Cタンパク質の蓄積量が低下すること、及び生理活性が低下した変異型のUNC5Cタンパク質がウシ体内で産生されることが包含される。本発明におけるUNC5C遺伝子領域の変異とは、典型的には、UNC5C遺伝子の発現が抑制される変異であり得る。そのような変異の具体例として、3'-UTR領域の169番目の塩基(UNC5C遺伝子の終始コドンの次の塩基を1番目として数えて169番目の意味)がアデニンからグアニンに置換する一塩基置換変異が挙げられる。なお、この169番目の塩基は、配列番号16に示す塩基配列においては432番目、配列番号20においては2962番目である。 The UNC5C (unc-5 homolog C) gene encodes a netrin receptor protein involved in nerve development. The mutation of the UNC5C gene region in the present invention is a mutation that decreases the function of the UNC5C gene in bovine. The decrease in the function of the UNC5C gene in the bovine body includes a decrease in the accumulated amount of wild-type UNC5C protein in the bovine body due to a decrease in the expression level of the UNC5C gene, and a mutant UNC5C protein with decreased physiological activity. It is included that it is produced in the bovine body. The mutation in the UNC5C gene region in the present invention can typically be a mutation that suppresses the expression of the UNC5C gene. A specific example of such a mutation is a single base substitution in which the 169th base of the 3'-UTR region (meaning the 169th base counting from the base codon next to the stop codon of the UNC5C gene) is replaced by adenine to guanine. Mutations. The 169th base is the 432th position in the base sequence shown in SEQ ID NO: 16 and the 2962nd position in SEQ ID NO: 20.
UNC5C遺伝子領域における変異が当該遺伝子の発現を抑制するかどうかは、例えば、下記実施例においても用いられているレポーターアッセイにより調べることができる。レポーターアッセイは周知の常法であり、そのためのキットも各種のものが市販されている。例えばルシフェラーゼレポーターアッセイの場合、UNC5C遺伝子領域のうちで変異部位を含む一定の領域をルシフェラーゼ遺伝子の上流又は下流に連結したコンストラクトを構築し、インビトロで該コンストラクトを発現させ、発現したルシフェラーゼの酵素活性に基づいてルシフェラーゼ遺伝子の発現が抑制されたかを評価すればよい。ルシフェラーゼの酵素活性が変異型コンストラクトで野生型コンストラクトよりも低下していた場合、その変異はUNC5C遺伝子の発現を抑制する変異であると判断することができる。 Whether a mutation in the UNC5C gene region suppresses the expression of the gene can be examined by, for example, a reporter assay used also in the following Examples. The reporter assay is a well-known conventional method, and various kits are commercially available. For example, in the case of a luciferase reporter assay, a construct in which a certain region including a mutation site in the UNC5C gene region is linked upstream or downstream of the luciferase gene is constructed, the construct is expressed in vitro, and the enzyme activity of the expressed luciferase is determined. Based on this, it may be evaluated whether the expression of the luciferase gene is suppressed. When the enzyme activity of luciferase is lower in the mutant construct than in the wild construct, it can be determined that the mutation is a mutation that suppresses the expression of the UNC5C gene.
核酸試料は特に限定されず、ゲノミックDNA試料、RNA試料(全RNA若しくはmRNA)、又はcDNA試料を用いることができる。cDNA試料は、ウシからRNAを分離し、これを鋳型とした逆転写反応により調製することができる。核酸試料としては、作業工程の簡便さから、ゲノミックDNA試料を好ましく用いることができる。 The nucleic acid sample is not particularly limited, and a genomic DNA sample, an RNA sample (total RNA or mRNA), or a cDNA sample can be used. A cDNA sample can be prepared by reverse transcription using RNA isolated from bovine as a template. As the nucleic acid sample, a genomic DNA sample can be preferably used because of the simplicity of the work process.
核酸試料を用いて遺伝子領域上の変異を調べる具体的な方法としては、例えば、核酸試料をPCR等の核酸増幅反応に付し、増幅断片の塩基配列に基づいて変異の有無を調べる方法が挙げられる。変異により野生型配列と変異型配列との間で制限酵素の認識部位に相違が生じる場合には、増幅断片の制限酵素断片長多型を解析することにより(すなわち周知のPCR-RFLP法により)変異の有無を調べることができるが、一般には、増幅断片の塩基配列を決定して変異の有無を調べる方法がより好ましい。 As a specific method for examining a mutation in a gene region using a nucleic acid sample, for example, a method of subjecting a nucleic acid sample to a nucleic acid amplification reaction such as PCR and examining the presence or absence of a mutation based on the base sequence of the amplified fragment can be mentioned. It is done. If there is a difference in the restriction enzyme recognition site between the wild-type sequence and the mutant sequence due to mutation, analyze the restriction fragment length polymorphism of the amplified fragment (ie, using the well-known PCR-RFLP method). Although the presence or absence of mutation can be examined, in general, the method of examining the presence or absence of mutation by determining the base sequence of the amplified fragment is more preferred.
UNC5C遺伝子領域の変異として、3'-UTR領域の169番目の塩基(配列番号16における第432番塩基)がアデニンからグアニンに置換する一塩基置換変異の有無を検出する場合であれば、当該部位を含むUNC5C遺伝子領域の一部(50bp〜1000bp程度の領域を増幅すれば十分である)をゲノミックDNA試料から核酸増幅法により増幅し、増幅断片の塩基配列を決定し、一塩基置換があるか否かを確認すればよい。配列番号18及び19に示すプライマーセットを用いてPCRを行えば、UNC5C遺伝子領域のうちで図1(配列番号17)に示した領域が増幅される。このプライマーは、3'-UTR領域の1番目〜231番目の領域を増幅するプライマーである。この増幅断片における169番目(配列番号16における第432番)の塩基を比較すると、一塩基置換がない場合はアデニンであり、一塩基置換がある場合はグアニンである。従って、当該一塩基置換変異の有無は、簡便には、配列番号16における第432番塩基が何であるかを確認することによって検出することができる。 As a mutation of the UNC5C gene region, if the presence or absence of a single nucleotide substitution mutation in which the 169th base of the 3′-UTR region (the 432th base in SEQ ID NO: 16) substitutes adenine for guanine is detected, the relevant site A part of the UNC5C gene region (including a region of about 50 bp to 1000 bp is sufficient) is amplified from a genomic DNA sample by nucleic acid amplification, and the base sequence of the amplified fragment is determined, and whether there is a single base substitution You should confirm whether or not. When PCR is performed using the primer sets shown in SEQ ID NOs: 18 and 19, the region shown in FIG. 1 (SEQ ID NO: 17) in the UNC5C gene region is amplified. This primer is a primer that amplifies the 1st to 231st regions of the 3′-UTR region. When the 169th base (No. 432 in SEQ ID NO: 16) in this amplified fragment is compared, it is adenine when there is no single base substitution, and it is guanine when there is a single base substitution. Therefore, the presence or absence of the single nucleotide substitution mutation can be easily detected by confirming what is the 432nd base in SEQ ID NO: 16.
本発明のウシの受胎率の判定方法では、UNC5C遺伝子における変異の有無を検出する。受胎率の指標となることが知られているCTTNBP2NL遺伝子(非特許文献1、2)を組み合わせて調べてもよい。いずれの遺伝子においても、変異型のアリルが受胎率の低さの指標となる。雌ウシについて一遺伝子を対象に変異の有無を調べた場合、片方のアリルが変異型アリルであれば、当該雌ウシは受胎率がやや低く、両方のアリルが変異型アリルであれば、当該雌牛は受胎率が低いと判定することができる。複数の遺伝子を対象に調べた場合であれば、変異型アリルの数が多いほど受胎率が低く、逆にいえば変異のない野生型アリルの数が多いほど受胎率が高いと判定することができる。雄ウシについても雌ウシと同様に受胎率判定が可能であり、雄ウシが変異型アリルを多く有すれば、該雄ウシが精子供与したウシ胎児は雌ウシにおいて受胎率が低いと判定することができる。複数の遺伝子を組み合わせて調べた場合の受胎率判定の効果は相加的である。従って、本発明の方法により受胎率が高いウシを選抜したい場合には、雄ウシ雌ウシともに、野生型アリルを多く持つ個体(変異型アリルを少なく持つ個体)を選抜して交配(人工授精も含む)させればよい。 In the method for determining the fertilization rate of the bovine of the present invention, the presence or absence of a mutation in the UNC5C gene is detected. You may investigate combining CTTNBP2NL gene (nonpatent literatures 1 and 2) known to become a fertility index. In any gene, the mutant allele is an indicator of low conception rate. When examining the presence or absence of mutations in one gene for a cow, if one allele is a mutant allele, the cow has a slightly lower conception rate, and if both alleles are mutant alleles, the cow Can be determined to have a low conception rate. If multiple genes are studied, the higher the number of mutant alleles, the lower the conception rate, and conversely, the higher the number of wild-type alleles without mutation, the higher the conception rate. it can. The conception rate can be determined for bulls in the same way as cows. If a bull has a large number of mutant alleles, it is determined that the calf fetus donated by the bull has a low conception rate in cows. be able to. The effect of determining the conception rate when combining a plurality of genes is additive. Therefore, when it is desired to select cattle with high conception rate by the method of the present invention, both bulls and cows are selected and mated (individual fertilization is also performed) by selecting individuals having a large amount of wild-type alleles (individuals having fewer mutant alleles). Included).
UNC5C遺伝子における上記定義の通りの変異は、ウシの受胎率の指標となるので、変異部位を含むウシゲノム上の領域を増幅するプライマーセット、すなわち、UNC5C遺伝子領域内の変異部位を含む領域を増幅するプライマーセットは、ウシの受胎率の判定試薬として提供することができる。なお、このプライマーセットは、変異を有しない野生型配列のウシ由来の核酸試料を鋳型としたPCRに用いれば、当然ながら、変異部位に対応する部位を含む変異のない配列の増幅断片が得られる。 Since the mutation as defined above in the UNC5C gene is an indicator of the conception rate of cattle, a primer set that amplifies a region on the bovine genome including the mutation site, that is, a region including the mutation site in the UNC5C gene region is amplified. The primer set can be provided as a reagent for determining the conception rate of cattle. In addition, if this primer set is used for PCR using a wild-type sequence bovine-derived nucleic acid sample having no mutation as a template, an amplified fragment of a sequence without a mutation including a site corresponding to the mutation site can be obtained. .
UNC5C遺伝子領域内の変異部位を含む領域を増幅するプライマーセットは、例えば、配列番号16における432番目の塩基を含むウシゲノム上の領域を増幅するプライマーセットであり得る。そのようなプライマーセットは、配列番号16に示す塩基配列中の第1番〜第431番塩基の領域内の部分領域に特異的にハイブリダイズするフォワード側プライマーと、配列番号16に示す塩基配列中の第433番〜第2036番塩基の領域内の部分領域に特異的にハイブリダイズするリバース側プライマーとのセットであり得る。なお、「フォワード側プライマー」とは、配列表に実際に示されている塩基配列の相補鎖にハイブリダイズするプライマーであり、「リバース側プライマー」とは、配列表に実際に示されている塩基配列にハイブリダイズするプライマーである。 The primer set for amplifying a region containing a mutation site in the UNC5C gene region can be, for example, a primer set for amplifying a region on the bovine genome containing the 432th base in SEQ ID NO: 16. Such a primer set includes a forward primer that specifically hybridizes to a partial region in the region of the first to 431 th bases in the base sequence shown in SEQ ID NO: 16, and the base sequence shown in SEQ ID NO: 16 And a reverse primer that specifically hybridizes to a partial region within the region of the 433th to 2036th bases. The “forward primer” is a primer that hybridizes to the complementary strand of the base sequence actually shown in the sequence listing, and the “reverse primer” is the base actually shown in the sequence listing. A primer that hybridizes to a sequence.
「特異的にハイブリダイズする」とは、通常のハイブリダイズの条件下において、対象とする領域にのみハイブリダイズし、その他の領域には実質的にハイブリダイズしないという意味である。「通常のハイブリダイズの条件下」とは、通常のPCRのアニーリングやプローブによる検出に用いられる条件下のことをいい、例えば、Taqポリメラーゼを用いたPCRの場合には、50mM KCl、10mM Tris-HCl(pH 8.3〜9.0)、1.5mM MgCl2といった一般的な緩衝液を用いて、54℃〜60℃程度の適当なアニーリング温度で反応を行なうことをいい、また、例えばノーザンハイブリダイゼーションの場合には、5 x SSPE、50%ホルムアミド、5 x Denhardt's solution、0.1〜0.5%SDSといった一般的なハイブリダイゼーション溶液を用いて、42℃〜65℃程度の適当なハイブリダイゼーション温度で反応を行なうことをいう。ただし、適当なアニーリング温度及びハイブリダイゼーション温度は、上記例示に限定されず、プライマー又はプローブのTm値及び実験者の経験則に基づいて定められ、当業者であれば容易に定めることができる。「実質的にハイブリダイズしない」とは、全くハイブリダイズしないか、するとしても対象とする領域にハイブリダイズする量よりも大幅に少なく、相対的に無視できる程度の微量しかハイブリダイズしないという意味である。 “Specifically hybridize” means that under normal hybridization conditions, it hybridizes only to the region of interest and does not substantially hybridize to other regions. “Normal hybridization conditions” refer to the conditions used for normal PCR annealing and probe detection. For example, in the case of PCR using Taq polymerase, 50 mM KCl, 10 mM Tris- The reaction is performed using a general buffer solution such as HCl (pH 8.3 to 9.0) and 1.5 mM MgCl 2 at an appropriate annealing temperature of about 54 ° C. to 60 ° C. For example, in the case of Northern hybridization Is to perform the reaction at an appropriate hybridization temperature of about 42 ° C. to 65 ° C. using a general hybridization solution such as 5 × SSPE, 50% formamide, 5 × Denhardt's solution, 0.1 to 0.5% SDS. . However, the appropriate annealing temperature and hybridization temperature are not limited to the above examples, and are determined based on the Tm value of the primer or probe and the empirical rule of the experimenter, and can be easily determined by those skilled in the art. “Substantially does not hybridize” means that it does not hybridize at all, or even if it is significantly less than the amount hybridized to the target region, and hybridizes only in a relatively negligible amount. is there.
そのような条件下で特異的にハイブリダイズするプライマーとしては、ハイブリダイズする部分領域と完全に相補的な塩基配列を有するプライマーが好ましいが、通常、10%以下の塩基が置換した配列を有するプライマーを用いても、対象とする部分領域にハイブリダイズして増幅が起きる場合が多い(ただし、「10%以下の塩基が置換した塩基配列」は、もとの塩基配列のうち3'末端の塩基以外の塩基が置換されていることが好ましい)。また、この分野で周知の通り、プライマーの5'末端側に例えば制限酵素認識配列等の任意の配列を付加しても、対象とする部分領域に特異的にハイブリダイズし、目的の領域を増幅することができる。 As a primer that specifically hybridizes under such conditions, a primer having a base sequence that is completely complementary to the hybridizing partial region is preferable, but usually a primer having a sequence in which 10% or less of the base is substituted. In many cases, amplification is caused by hybridizing to the target partial region even when using (“base sequence substituted with 10% or less base” is the base at the 3 ′ end of the original base sequence) It is preferable that a base other than is substituted). As is well known in this field, even if an arbitrary sequence such as a restriction enzyme recognition sequence is added to the 5 ′ end of the primer, it hybridizes specifically to the target partial region and amplifies the target region. can do.
従って、配列番号16に示す塩基配列中の第1番〜第431番塩基の領域内の部分領域に特異的にハイブリダイズするフォワード側プライマーには、配列番号16に示す塩基配列中の第1番〜第431番塩基の領域内の連続する15塩基以上、好ましくは18塩基以上の塩基配列からなるプライマー、及び該塩基配列のうち10%以下の塩基が置換した塩基配列からなるプライマー、並びにこれらのプライマーの5'末端側に付加配列を有するプライマーが包含される。すなわち、該フォワード側プライマーは、配列番号16に示す塩基配列中の第1番〜第431番塩基の領域内の連続する15塩基以上の塩基配列又は該塩基配列のうち10%以下の塩基が置換した塩基配列をその3'末端側に含むプライマーであり得る。 Therefore, the forward primer that specifically hybridizes to the partial region in the region of the first to 431th bases in the base sequence shown in SEQ ID NO: 16 is the first primer in the base sequence shown in SEQ ID NO: 16. To a primer consisting of a base sequence of 15 bases or more, preferably 18 bases or more in the region of No. 431 base, a primer consisting of a base sequence substituted with 10% or less of the base sequence, and these A primer having an additional sequence on the 5 ′ end side of the primer is included. That is, in the forward primer, 15 or more consecutive base sequences in the region of the 1st to 431rd bases in the base sequence shown in SEQ ID NO: 16 or 10% or less of the base sequences are substituted It may be a primer containing the base sequence on the 3 ′ end side.
同様に、配列番号16に示す塩基配列中の第433番〜第2036番塩基の領域内の部分領域に特異的にハイブリダイズするリバース側プライマーには、配列番号16に示す塩基配列中の第433番〜第2036番塩基の領域内の連続する15塩基以上、好ましくは18塩基以上の塩基配列と相補的な配列からなるプライマー、及び該相補的な配列のうち10%以下の塩基が置換した塩基配列からなるプライマー、ならびにこれらのプライマーの5'末端側に付加配列を有するプライマーが包含される。すなわち、該リバース側プライマーは、配列番号16に示す塩基配列中の第433番〜第2036番塩基の領域内の連続する15塩基以上からなる塩基配列と相補的な配列又は該相補的な配列のうち10%以下の塩基が置換した塩基配列をその3'末端側に含むプライマーであり得る。 Similarly, the reverse primer that specifically hybridizes to the partial region in the region of the 433th to 2036th bases in the base sequence shown in SEQ ID NO: 16 is the 433 in the base sequence shown in SEQ ID NO: 16. A primer composed of a sequence complementary to a base sequence of 15 bases or more, preferably 18 bases or more in the region of No. 2036 bases, and a base substituted by 10% or less of the complementary sequence Primers comprising sequences as well as primers having additional sequences on the 5 ′ end side of these primers are included. That is, the reverse primer is a sequence complementary to the base sequence consisting of 15 or more bases in the region of the 433th to 2036th bases in the base sequence shown in SEQ ID NO: 16, or the complementary sequence Among them, the primer may contain a base sequence substituted with 10% or less of the base on the 3 ′ end side.
下記実施例で用いられている、配列番号18に示す塩基配列からなるプライマーと配列番号19に示す塩基配列からなるプライマーとのセットは、実施例で同定されたUNC5C遺伝子領域における一塩基置換変異を検出するための好ましいプライマーセットの一例であるが、ウシの受胎率の判定試薬に使用可能なUNC5C遺伝子領域を増幅するプライマーセットはこれに限定されない。 The set of the primer consisting of the base sequence shown in SEQ ID NO: 18 and the primer consisting of the base sequence shown in SEQ ID NO: 19 used in the following example is a single base substitution mutation in the UNC5C gene region identified in the example. Although it is an example of the preferable primer set for detecting, the primer set which amplifies the UNC5C gene area | region which can be used for the determination reagent of a bovine conception rate is not limited to this.
受胎率の判定試薬は、上記したプライマーセットのみからなるものであってもよいし、プライマーを緩衝液等に溶解させた形態であってもよく、また、乾燥させたプライマーと緩衝液等とをセットにした形態であってもよい。さらに、該試薬は、プライマーの分解防止等に有用な各種添加剤等を含んでいてもよい。 The fertility determination reagent may be composed of only the primer set described above, or may be in a form in which the primer is dissolved in a buffer solution or the like, and a dried primer and a buffer solution or the like. It may be in the form of a set. Further, the reagent may contain various additives useful for preventing the decomposition of the primer.
上記したウシの受胎率の判定試薬は、他の試薬類と適宜に組み合わせて、ウシの受胎率の判定キットとして提供することができる。PCR等の核酸増幅法に必要なプライマー以外の他の試薬類は周知である。例えば、該判定キットには、上記した受胎率の判定試薬のほか、核酸増幅反応の反応液を調製するための緩衝液や、耐熱性ポリメラーゼ等がさらに含まれ得る。 The above-described determination reagent for bovine conception can be appropriately combined with other reagents to provide a determination kit for bovine conception. Reagents other than the primers necessary for nucleic acid amplification methods such as PCR are well known. For example, the determination kit may further include a buffer solution for preparing a reaction solution for nucleic acid amplification reaction, a heat-resistant polymerase, and the like, in addition to the above-described conception rate determination reagent.
以下、本発明を実施例に基づきより具体的に説明する。もっとも、本発明は下記実施例に限定されるものではない。以下の記載では、特に説明がない場合には、J. Sambrook & D. W. Russell (Ed.), Molecular cloning, a laboratory manual (3rd edition), Cold Spring Harbor Press, Cold Spring Harbor, New York (2001) に記載の方法、あるいはそれを適宜修飾又は改変した方法により行なった。また、市販の試薬キットや測定装置を用いている場合には、特に説明が無い場合、それらに添付のプロトコールの指示に従って行なった。 Hereinafter, the present invention will be described more specifically based on examples. However, the present invention is not limited to the following examples. In the following description, unless otherwise specified, J. Sambrook & DW Russell (Ed.), Molecular cloning, a laboratory manual (3rd edition), Cold Spring Harbor Press, Cold Spring Harbor, New York (2001) This was carried out by the method described, or a method that was appropriately modified or modified. In addition, when using commercially available reagent kits and measuring devices, the procedures were performed according to the instructions of the attached protocol unless otherwise specified.
1.受胎率に関与する遺伝子の同定
(1) ウシUNC5C遺伝子の塩基配列の決定
まず、ホルスタイン種集団から受胎率育種価が50%以上である受胎率の良いウシ(176頭)及び受胎率育種価が42%未満である受胎率の悪いウシ(646頭)からなる集団について、全染色体をカバーする43,851個のSNPを用いて受胎率に関連するウシ染色体の領域を同定した。このうち、強い関連の見られた第6番染色体上の受胎率制御領域に存在するUNC5C遺伝子の発現の制御に関わる領域の塩基配列を解読し、受胎率の良いウシと悪いウシを比較したところ、悪いウシに特異的な一塩基置換変異を見出した。
1. Identification of genes involved in conception rate
(1) Determination of the base sequence of bovine UNC5C gene First of all, cows with good conception rate (176 heads) with a conception breeding value of 50% or higher from the Holstein population and those with a conception rate breeding value of less than 42% For a population of bad cattle (646 heads), 43,851 SNPs covering all chromosomes were used to identify regions of the bovine chromosome related to conception rate. Of these, the base sequence of the region involved in the regulation of UNC5C gene expression in the fertility control region on chromosome 6 that was found to be strongly related was decoded and compared with cattle with good fertility and bad cattle. We found a single base substitution mutation specific to bad cattle.
なお、受胎率育種価は、河原孝吉ら、The Japanese Journal of Zootechnical Science 81(2), p.121-132, 2010-05-25の手法に従い、以下の通りに決定した。 The fertility breeding value was determined as follows according to the method of Takayoshi Kawahara et al., The Japanese Journal of Zootechnical Science 81 (2), p.121-132, 2010-05-25.
分析には、1990年1月から2009年7月までの期間、北海道の牛群検定を受検したホルスタイン雌牛1,218,264頭の初産分娩後における受胎の有無(0または1)を示す記録2,391,649を利用し、分析に用いる記録は、以下の3条件を満たすものとした。
・18〜42ヶ月齢で初産分娩し、18〜54ヶ月齢で授精していること
・初産分娩後21〜160日以内に初回授精し、345日以内の授精記録であること
・2産次の分娩記録においては、在胎日数が265日〜295日であること
For the period from January 1990 to July 2009, we used records 2,391,649 indicating the presence or absence of pregnancy (0 or 1) after the first parturition of 1,218,264 Holstein cows who received a bovine herd test in Hokkaido, The records used for analysis satisfy the following three conditions.
・ First delivery at the age of 18-42 months, fertilization at the age of 18-54 months ・ First insemination within 21-160 days after the delivery of the first delivery, record of insemination within 345 days In the birth record, the gestational age should be between 265 and 295 days
遺伝評価に使用したモデルは、単形質・閾値アニマルモデルであり、母数効果として授精月齢、授精月、及び分娩から授精までの日数、変量効果として授精した牛群・年・季節、授精した種雄牛・年、育種価、雌牛ごとの授精の繰り返し、及び残差を用いた。 The model used for the genetic evaluation is a monomorphic / threshold animal model. The population effect is the age of insemination, the month of insemination, the number of days from parturition to insemination, the cow group / year / season inseminated as a random effect, and the insemination Cattle / year, breeding value, repetition of insemination for each cow, and residual were used.
(2) 一塩基置換変異がUNC5C遺伝子の発現量に及ぼす影響
UNC5C遺伝子の高受胎率型と低受胎率型それぞれのゲノム断片をつないだルシフェラーゼ遺伝子のコンストラクトを、ヒト顆粒膜細胞由来株COV434に導入し、ルシフェラーゼ遺伝子の発現をルシフェラーゼ酵素の活性測定にて定量した。なお、コンストラクトの作製及びルシフェラーゼアッセイには、dual-luciferase reporter assay system (Promega, 米国ミシガン州Madison)を用いた。プライマーUNC5C-F及びUNC5C-Rを用いたPCR(後述)により、高受胎率型配列及び低受胎率型配列を有する牛のゲノミックDNAからそれぞれ図1に示す領域(配列番号16における第264番〜第494番塩基の領域、配列番号17)を増幅し、各増幅断片を上記キットに含まれるルシフェラーゼ遺伝子の下流に連結してアッセイ用のコンストラクトとした。
(2) Effect of single nucleotide substitution mutation on the expression level of UNC5C gene
The luciferase gene construct that connects the genomic fragments of the high and low conception types of UNC5C gene was introduced into human granulosa cell-derived strain COV434, and the expression of the luciferase gene was quantified by measuring the activity of the luciferase enzyme. . Note that a dual-luciferase reporter assay system (Promega, Madison, Michigan, USA) was used for construct production and luciferase assay. By PCR (described later) using primers UNC5C-F and UNC5C-R, the regions shown in FIG. The region of the 494th base, SEQ ID NO: 17) was amplified, and each amplified fragment was ligated downstream of the luciferase gene contained in the kit to obtain an assay construct.
その結果、UNC5Cの高受胎率遺伝子型では低受胎率遺伝子型と比べ有意に活性が上昇していることがわかった(表2)。一塩基置換変異の結果、UNC5Cの発現を抑制することが受胎率低下をもたらすと考えられる。 As a result, it was found that UNC5C high fertility genotype had significantly increased activity compared to low conception genotype (Table 2). As a result of single nucleotide substitution mutations, suppression of UNC5C expression is thought to reduce the conception rate.
(3) UNC5C遺伝子変異が受胎率育種価に及ぼす影響
UNC5C遺伝子の受胎率育種価に対する影響を調べるため、種雄牛2528頭と雌牛1418頭のDNAを用いて遺伝子型を調べ、受胎率育種価を比較した。その結果、高受胎率遺伝子型をホモで有する個体では、低受胎率遺伝子型をホモで有する個体と比べて受胎率育種価が有意に高いことがわかった(表3)。このことから、低受胎率遺伝子型のUNC5C遺伝子を有するウシの生産効率は、高受胎率遺伝子型UNC5C遺伝子を有する個体と比較して減少することが考えられる。
(3) Effect of UNC5C gene mutation on fertility breeding value
To examine the effect of the UNC5C gene on the fertility breeding value, we examined the genotypes using the DNA of 2528 bulls and 1418 cows and compared the fertility breeding values. As a result, it was found that the individuals having a high conception genotype homozygously had a significantly higher conception breeding value than those individuals having a low conception genotype homozygous (Table 3). From this, it is considered that the production efficiency of cattle having a low conception rate genotype UNC5C gene is reduced compared to individuals having a high conception rate genotype UNC5C gene.
2.ウシのゲノミックDNA上のUNC5C遺伝子の変異の有無の確認
受胎率の悪いウシに認められた変異部位を含むDNA断片を増幅するためのプライマーUNC5C-F、UNC5C-Rを合成した。配列表の配列番号18、19にそれぞれプライマーUNC5C-F、UNC5C-Rの塩基配列を示す。
2. Confirmation of the presence or absence of mutations in the UNC5C gene on bovine genomic DNA Primers UNC5C-F and UNC5C-R were synthesized to amplify DNA fragments containing mutation sites found in cattle with poor conception rates. The nucleotide sequences of primers UNC5C-F and UNC5C-R are shown in SEQ ID NOs: 18 and 19, respectively.
ウシの血液(抗擬固剤としてEDTA、ヘパリンを含む)より、自動核酸分離装置NA-1000(クラボウ社製)を用いてゲノミックDNAを調製した。これらのゲノミックDNAを鋳型とし、プライマーUNC5C-FとUNC5C-Rを用いたPCR (94℃で20秒、60℃で30秒、72℃で1分間からなる工程を1サイクルとした35サイクル反応)を行い、3730蛍光DNAシークエンサー(アプライドバイオシステムズ社製)を用いてPCR生成物の塩基配列を比較した。高受胎率型UNC5C遺伝子を鋳型にPCRで増幅させたDNA断片(配列番号16における第264番〜第494番塩基の領域、配列番号17及び図1)では、169番目の塩基がアデニン(A)であるが、低受胎率型由来の増幅断片ではグアニン(G)であった。図2に示すように、当該部位における塩基を調べることにより、UNC5C遺伝子の高受胎率型と低受胎率型を簡便に見分けることができることが確認された。 Genomic DNA was prepared from bovine blood (including EDTA and heparin as an anti-pseudo-solid agent) using an automatic nucleic acid separator NA-1000 (manufactured by Kurabo Industries). PCR using these genomic DNAs as templates and primers UNC5C-F and UNC5C-R (35-cycle reaction with a cycle consisting of 20 seconds at 94 ° C, 30 seconds at 60 ° C, 1 minute at 72 ° C) The base sequences of the PCR products were compared using a 3730 fluorescent DNA sequencer (Applied Biosystems). In a DNA fragment amplified by PCR using the high fertility type UNC5C gene as a template (regions of the 264th to 494th bases in SEQ ID NO: 16, SEQ ID NO: 17 and FIG. 1), the 169th base is adenine (A) However, the amplified fragment derived from the low conception type was guanine (G). As shown in FIG. 2, it was confirmed that the high and low conception types of the UNC5C gene can be easily distinguished by examining the bases at the site.
受胎率は複数の遺伝子が関わっている量的形質であるが、本発明により、UNC5C遺伝子は受胎率制御に関わる遺伝子の一部であり、ここで述べるDNA診断法で確実にUNC5C遺伝子における変異の有無を判定し、ウシの受胎率を判別可能であることが明らかとなった。 The conception rate is a quantitative trait involving multiple genes, but according to the present invention, the UNC5C gene is part of the gene involved in the control of conception rate. It was clarified that the conception rate of cattle can be determined by determining the presence or absence.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014183157A JP6120448B2 (en) | 2014-09-09 | 2014-09-09 | Method for determining the conception rate of cattle |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014183157A JP6120448B2 (en) | 2014-09-09 | 2014-09-09 | Method for determining the conception rate of cattle |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016054677A JP2016054677A (en) | 2016-04-21 |
| JP6120448B2 true JP6120448B2 (en) | 2017-04-26 |
Family
ID=55756193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014183157A Expired - Fee Related JP6120448B2 (en) | 2014-09-09 | 2014-09-09 | Method for determining the conception rate of cattle |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6120448B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118910273B (en) * | 2024-08-02 | 2025-03-25 | 中国科学院遗传与发育生物学研究所 | A SNP molecular marker related to sheep litter size and its application |
| CN120400374B (en) * | 2025-07-01 | 2025-09-09 | 山东省农业科学院畜牧兽医研究所 | A SNP molecular marker associated with conception rate of young cows, a detection product and its application |
-
2014
- 2014-09-09 JP JP2014183157A patent/JP6120448B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016054677A (en) | 2016-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Flisikowski et al. | A novel mutation in the maternally imprinted PEG3 domain results in a loss of MIMT1 expression and causes abortions and stillbirths in cattle (Bos taurus) | |
| KR101595011B1 (en) | Novel SNP marker for discriminating number of nipple of Pig and use thereof | |
| EP2310528B1 (en) | A genetic marker test for brachyspina and fertility in cattle | |
| CN102168136B (en) | Application of LHCGR Gene as Molecular Marker in Chinese Holstein Dairy Cows | |
| CN105087820A (en) | FSHR (follicle stimulating hormone receptor) gene based molecular marker related to porcine reproduction traits as well as detection method and application of molecular marker | |
| JP6120448B2 (en) | Method for determining the conception rate of cattle | |
| JP5924307B2 (en) | Method for determining the conception rate of cattle | |
| JP7041415B2 (en) | DNA markers, and test methods and test kits using them | |
| JP2008148612A (en) | Tools for identification of chicken breeds and their use | |
| Pal et al. | Polymorphism of growth hormone gene and its association with expected milk production traits in dairy bulls | |
| JP6562411B2 (en) | Method for determining success rate of bovine fertilized egg transplantation | |
| JP5897704B2 (en) | Detection of Brachyspina mutation | |
| JP5281775B2 (en) | Single nucleotide polymorphisms involved in bovine marbling and their use | |
| JP6683642B2 (en) | Method for determining inosin acid content in meat after slaughter in bovine individuals | |
| US20070026404A1 (en) | Production characteristics of cattle | |
| JP2023137354A (en) | Test methods, probes, and primers to determine high fertility | |
| US8101354B2 (en) | Method for screening for a tobiano coat color genotype | |
| JP5281920B2 (en) | Single nucleotide polymorphisms involved in bovine marbling and their use | |
| JP4430063B2 (en) | Method for testing congenital eye disease detecting mutation in WFDC1 | |
| CN121915161A (en) | Application of SNP molecular marker related to nipple number heterosis on pig chromosome 6 | |
| CN105671172A (en) | Molecular marker relevant with reproduction traits of pigs and detection method and application thereof | |
| CN105713970A (en) | Porcine reproductive trait-related molecular marker based on KISS-1 gene and detection method and application of molecular marker | |
| Georgescu et al. | The correlation of production characteristics with the genetic variants of the encoding locus of β-lactoglobulin in three sheep breeds from Romania | |
| Penedo et al. | Molecular genetic testing and karyotyping in the horse | |
| KR101647288B1 (en) | New primer and genotyping method of sla-2 using genomic pcr based direct sequencing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160823 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161021 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170307 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170327 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6120448 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |